SHORT AND LONG TERM SAFETY AND EFFICACY OF HIGH DOSE ATORVASTATIN IN REDUCING THE LEVEL OF hsCRP AND MAJOR ADVERSE CARDIAC EVENTS IN A GROUP OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN EASTERN INDIA. - Current Issue

SHORT AND LONG TERM SAFETY AND EFFICACY OF HIGH DOSE ATORVASTATIN IN REDUCING THE LEVEL OF hsCRP AND MAJOR ADVERSE CARDIAC EVENTS IN A GROUP OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN EASTERN INDIA. - Current Issue - IJAR